Southern Clinical Research Man is categorized under Management Services in Tallahassee, FL and active since 2008.
Southern Clinical Research Man was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Management Services business, which does work in the B2B market, and is classified as a Management Services, under code number 561110 by the NAICS.
If you are seeking more information, feel free to contact Lenore Beckett at the company’s single location by writing to 2910 Kerry Forest Parkway, Tallahassee, Florida FL 32309 or by phoning (615) 461-8627. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Southern Clinical Research Man |
| Contact Person: | Lenore Beckett |
| Address: | 2910 Kerry Forest Parkway, Tallahassee, Florida 32309 |
| Phone Number: | (615) 461-8627 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Management Services |
| SIC Code: | 8741 |
| NAICS Code: | 561110 |
| Share This Business: |
Southern Clinical Research Man was started in 2008 to provide professional Management Services under the SIC code 8741 and NAICS code 561110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Lenore Beckett for inquiries that concern Southern Clinical Research Man by calling the company number (615) 461-8627, as your correspondence is most welcome. Additionally, the physical location of the single location of Southern Clinical Research Man can be found at the coordinates 30.541632,-84.226181 as well as the street address 2910 Kerry Forest Parkway in Tallahassee, Florida 32309.
For its online presence, you may visit Southern Clinical Research Man’s website at and engage with its social media outlets through on Twitter and on Facebook.